These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32997323)
1. From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD). He X; Zhang M; Zhao C; Zheng P; Zhang X; Xu J Virol Sin; 2021 Apr; 36(2):167-175. PubMed ID: 32997323 [TBL] [Abstract][Full Text] [Related]
2. Is a multivalent hand, foot, and mouth disease vaccine feasible? Klein M; Chong P Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802 [TBL] [Abstract][Full Text] [Related]
3. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Fang CY; Liu CC Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317 [TBL] [Abstract][Full Text] [Related]
4. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Mao Q; Wang Y; Bian L; Xu M; Liang Z Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364 [TBL] [Abstract][Full Text] [Related]
5. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Zhang X; Zhang Y; Li H; Liu L Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613612 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model. Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178 [TBL] [Abstract][Full Text] [Related]
7. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102 [TBL] [Abstract][Full Text] [Related]
8. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies. Fang CY; Liu CC Expert Opin Drug Discov; 2022 Jan; 17(1):27-39. PubMed ID: 34382876 [TBL] [Abstract][Full Text] [Related]
9. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles. Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790 [TBL] [Abstract][Full Text] [Related]
10. Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD). Bello AM; Roshorm YM Biologicals; 2022 Sep; 79():1-9. PubMed ID: 36089444 [TBL] [Abstract][Full Text] [Related]
11. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice. Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China. Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446 [TBL] [Abstract][Full Text] [Related]
13. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Mao QY; Wang Y; Bian L; Xu M; Liang Z Expert Rev Vaccines; 2016 May; 15(5):599-606. PubMed ID: 26732723 [TBL] [Abstract][Full Text] [Related]
14. Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease. Anasir MI; Poh CL Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871133 [TBL] [Abstract][Full Text] [Related]
15. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540 [TBL] [Abstract][Full Text] [Related]
16. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Zhou Y; Li JX; Jin PF; Wang YX; Zhu FC Expert Rev Vaccines; 2016 Jul; 15(7):803-13. PubMed ID: 27206811 [TBL] [Abstract][Full Text] [Related]
17. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182 [TBL] [Abstract][Full Text] [Related]
18. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716 [TBL] [Abstract][Full Text] [Related]
19. The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine. Wang J; Jiang L; Zhang C; He W; Tan Y; Ning C Vaccine; 2021 Jun; 39(25):3319-3323. PubMed ID: 33994239 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection. Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]